Iterum Therapeutics plc financial data

Symbol
ITRM on Nasdaq
Location
3 Dublin Landings, North Wall Quay, Dublin 1, Ireland
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 152 % +1.08%
Debt-to-equity -679 % -13.5%
Return On Equity 437 % -22.7%
Return On Assets -75.5 % +33.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44.7M shares +96.7%
Entity Public Float 19.2M USD +40.1%
Common Stock, Value, Issued 421K USD +154%
Weighted Average Number of Shares Outstanding, Basic 39.9M shares +141%
Weighted Average Number of Shares Outstanding, Diluted 39.9M shares +141%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 6M USD -80.4%
General and Administrative Expense 10.9M USD +42.7%
Operating Income (Loss) -17.8M USD +53.5%
Nonoperating Income (Expense) -6M USD -158%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -23.8M USD +14.9%
Income Tax Expense (Benefit) 280K USD -26.7%
Net Income (Loss) Attributable to Parent -24.1M USD +15%
Earnings Per Share, Basic 0 USD/shares +59.8%
Earnings Per Share, Diluted 0 USD/shares +59.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13M USD +162%
Inventory, Net 948K USD
Assets, Current 14.9M USD +8.73%
Property, Plant and Equipment, Net 12K USD -68.4%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 19.1M USD
Other Assets, Noncurrent 19K USD -95.3%
Assets 34M USD +140%
Accounts Payable, Current 1.19M USD +44.6%
Employee-related Liabilities, Current 608K USD -54.9%
Accrued Liabilities, Current 3.95M USD +74.8%
Liabilities, Current 5.53M USD -67%
Operating Lease, Liability, Noncurrent 16K USD -98.6%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 37.9M USD +51.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -497M USD -5.09%
Stockholders' Equity Attributable to Parent -3.89M USD +64.4%
Liabilities and Equity 34M USD +140%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.06M USD +76.6%
Net Cash Provided by (Used in) Financing Activities -8.39M USD -216%
Net Cash Provided by (Used in) Investing Activities 7.21M USD +41.2%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 42.1M shares +154%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.5M USD -970%
Deferred Tax Assets, Valuation Allowance 44.6M USD +6.92%
Operating Lease, Liability 20K USD -95.7%
Depreciation 7K USD 0%
Payments to Acquire Property, Plant, and Equipment 2K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -24.1M USD +15%
Lessee, Operating Lease, Liability, to be Paid 20K USD -96%
Property, Plant and Equipment, Gross 320K USD -11.8%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18K USD -95.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 20K USD -95%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure -23.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11K USD -83.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 300K USD -25.2%
Deferred Tax Assets, Operating Loss Carryforwards 44.5M USD +7.25%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 1.91M USD -5.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 300K USD +4.17%
Operating Lease, Payments 253K USD -27.7%
Additional Paid in Capital 493M USD
Amortization of Intangible Assets 342K USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%